Anticonvulsant activity and selective inhibition of nicotinamide adenine dinucleotide-dependent oxidations by 1,3,5-trisubstituted pyrazolines.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006885:Hydroxybutyrates / Q000378:metabolism; D066298:In Vitro Techniques; D007656:Ketoglutaric Acids / Q000378:metabolism; D008297:Male; D051379:Mice; D009243:NAD / Q000037:antagonists & inhibitors*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011720:Pyrazoles / Q000138:chemical synthesis / Q000494:pharmacology*; D011773:Pyruvates / Q000378:metabolism; D051381:Rats
D000927:Anticonvulsants; D006885:Hydroxybutyrates; D007656:Ketoglutaric Acids; D011720:Pyrazoles; D011773:Pyruvates; D009243:NAD; D010433:Pentylenetetrazole